[The kinetics of apical cicatrization. An experimental study apropos of 25 cases with radiologic imaging].
The conventional usage of endo-canalar antiseptic of Rockle's type (SEPTODONT Laboratory) and the application of a standard protocol during two seances have shown: a 68% successful rate of healing at six months post therapeutic follow up, the diameter decrease of radiological images of peri-apical lesions, more than 80% in relative value; for about 20 teeth drawned lots (in a prospective study). This reduction of 33% at least at the maxillary and 50% at the mandible may be a reliable indicator for an endodontic surgical decision or fixed prosthetic rehabilitation report since the third month (especially peri-apical lesions of more than five millimetres of diameter). The respect of the security apical-limit of the root canal filling is fundamental. The second Senegalese (Dakar) serial will permit us to evaluate the use of calcium hydroxide in mediate and prolonged canalar disinfection.
Gaye
F
F
Service d'Odontologie Conservatrice Endodontie Institut d'Odonto-Stomatologie-UCAD-Dakar-Sénégal.
Mbaye
M
M
Paye
E H
EH
D000328:Adult; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D003407:Creosote / Q000627:therapeutic use; D003790:Dental Pulp Necrosis / Q000628:therapy; D003793:Dental Restoration, Permanent; D004338:Drug Combinations; D005260:Female; D005500:Follow-Up Studies; D005566:Formocresols / Q000627:therapeutic use; D006171:Gutta-Percha / Q000627:therapeutic use; D006801:Humans; D006847:Hydrocarbons, Iodinated / Q000627:therapeutic use; D008297:Male; D008334:Mandible; D008437:Maxilla; D010483:Periapical Diseases / Q000000981:diagnostic imaging / Q000628:therapy*; D011446:Prospective Studies; D011859:Radiography; D012387:Root Canal Filling Materials / Q000627:therapeutic use; D012388:Root Canal Irrigants / Q000627:therapeutic use*; D012390:Root Canal Therapy; D013223:Statistics as Topic; D013943:Thymol / Q000627:therapeutic use; D019227:Tooth Apex / Q000000981:diagnostic imaging / Q000187:drug effects / Q000503:physiopathology*; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects
D000891:Anti-Infective Agents, Local; D004338:Drug Combinations; D005566:Formocresols; D006847:Hydrocarbons, Iodinated; D012387:Root Canal Filling Materials; D012388:Root Canal Irrigants; D013943:Thymol; D003407:Creosote; C034472:Septodont; D006171:Gutta-Percha